Covid-19 Antigen Control(L)

Product Description

Negative control of Covid-19 Antigen are clear and transparent liquids, and are suitable for quality control of Covid-19 Antigen test reagents.

Usage

This product can be used directly without further dilution.

Before use, turn the dropping bottle upside down to mix the contents.

Do not shake the dropping bottle to avoid foaming.

Product information

Attentions

1. Stable for 12 months at 2-8℃. Open vial stability of 30 days at 2~8℃. Only the required amount is taken for each use, and the remaining samples can not be returned to the bottle.

2. This product is only used for in vitro diagnosis. Avoid direct contact to mouth, eyes and skin. - The reagents were treated according to routine laboratory precautions.

Shenzhen Kisshealh Biotechnology Co., Ltd., located in the Pingshan District, Shenzhen, P.R. China. is a diagnostics company focused on the development and manufacture of IVD tests at the Point-of-Care with highly innovative proprietary technology.

We focused on the emerging markets of in vitro pathological diagnosis and immunodiagnosis. We developed, manufactured and successfully launched the in vitro immunodiagnosis platform for cancer and the POCT for infectious, genetic and chronic diseases.

<span style="color: rgb(33, 33, 33); text-transform: none; text-indent: 0px; letter-spacing: normal;" initial;"="" initial;="" 0px;="" normal;="" 255);="" 255,="" rgb(255,="" 2;="" !important;="" inline="" none;="" 600;="" 14px;="" sans-serif;="" arial,="" roboto,="" w3",="" gb="" sans="" "hiragino="" gb",="" hei",="" micro="" "wenquanyi="" sans",="" "droid="" arimo,="" freesans,="" yahei",="" "microsoft="" helvetica,="" grande",="" "lucida="" ui",="" segoe="">At Kissh we work every day to shape the future of in-vitro diagnostic testing. And our people are our best asset, the reason for our track record and our strength while we are moving forward. We live by our fundamental values and incorporate them in everything that we do. Our best asset is ‘Step Forward Every Second’